| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $12.1B | $11.1B | $13.7B | $19.1B | $12.4B | $8.7B | $9.6B | — |
| Cost of Revenue | $10.2B | $9.6B | $11.5B | $13.4B | $9.2B | $7.6B | $8.1B | — |
| Gross Profit | $1.9B | $1.5B | $2.2B | $5.8B | $3.2B | $1.1B | $0.9B | $1.5B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $0.5B | $0.5B | $0.5B | $0.5B | $0.4B | $0.4B | $0.4B | $0.3B |
| Operating Income | $0.8B | $0.6B | $1.3B | $4.8B | $2.5B | $0.4B | $-1.1B | $0.9B |
| Net Income | $0.5B | $0.2B | $1.2B | $3.6B | $1.6B | $0.7B | $-1.1B | $0.5B |
| EPS (Basic) | $1.70 | $0.55 | $3.52 | $10.17 | $4.31 | $1.76 | $-2.78 | $1.22 |
| EPS (Diluted) | $1.70 | $0.55 | $3.50 | $10.06 | $4.27 | $1.75 | $-2.78 | $1.22 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $24.5B | $22.9B | $23.0B | $23.4B | $22.0B | $19.8B | $19.3B | $20.1B |
| Current Assets | $5.2B | $4.5B | $4.7B | $6.6B | $5.3B | $3.5B | $3.7B | $4.2B |
| Cash & Equivalents | $0.3B | $0.3B | $0.3B | $0.7B | $0.8B | $0.6B | $0.5B | $0.8B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $4.0B | $4.2B | $3.9B | $5.5B | $4.8B | $3.1B | $2.6B | $2.5B |
| Stockholders' Equity | $12.1B | $11.5B | $12.3B | $12.1B | $10.6B | $9.6B | $9.2B | $10.4B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.8B | $1.3B | $2.4B | $3.9B | $2.2B | $1.6B | $1.1B | $1.4B |
| Investing Cash Flow | $-1.3B | $-1.3B | $-1.3B | $-1.3B | $-1.3B | $-1.2B | $-1.4B | $-1.9B |
| Capital Expenditures | $1.4B | $1.3B | $1.4B | $1.2B | $1.3B | $1.2B | $1.3B | $1.0B |
| Financing Cash Flow | $0.5B | $-0.1B | $-1.5B | $-2.7B | $-0.7B | $-0.3B | $-0.1B | $-0.7B |